Clinical Trial Update: 2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091) [Phase 3]

View source ↗

Summary

Phase 3 trial update on two doses of an approved drug being studied for a new indication to prevent postoperative nausea and vomiting. The study status is Compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Postoperative Nausea and Vomiting | Phase 3 | Status: COMPLETED